Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Parkinson's Disease
Interventions
DRUG

levodopa-carbidopa

novel levodopa/carbidopa formulation or a reference levodopa/carbidopa formulation

Trial Locations (9)

Unknown

Fundacion Alfredo Thomson, Buenos Aires

Hospital Posadas, Buenos Aires

Hospital Ramos Mejía, Buenos Aires

Hospital Sirio Libanés, Buenos Aires

Instituto Frenopático, Buenos Aires

nstituto INEBA, Buenos Aires

Policlínica Bancaria, Buenos Aires

Fundación Rosarina de Neuro-Rehabilitación, Rosario

Hospital San Bernardo, Salta

Sponsors
All Listed Sponsors
lead

Osmotica Pharmaceutical US LLC

INDUSTRY